OCRHIPAA Privacy Rule

HIPAA Incidental Disclosures (45 CFR 164.502(a)(1)(iii))

Incidental disclosures that occur as a by-product of an otherwise permitted use or disclosure are not violations, provided reasonable safeguards and minimum necessary policies are applied.

Primary source

45 CFR 164.502(a)(1)(iii) — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-E/section-164.502#p-164.502(a)(1)(iii)

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

45 CFR 164.502(a)(1)(iii)(1)(iii)) recognizes that some disclosures of PHI are an unavoidable by-product of legitimate operations — a name called in a waiting room, a chart visible at a nursing station, a conversation between providers overheard in a corridor. The Privacy Rule does not treat these as violations, provided two conditions hold: the disclosure is incident to a use or disclosure otherwise permitted by the rule, and reasonable safeguards plus minimum necessary policies have been applied.

OCR has consistently emphasized that the safeguard standard is contextual, not absolute. A small practice is not required to retrofit private rooms or build sound-isolation walls. Reasonable measures might include speaking quietly in shared spaces, positioning monitors away from public view, using identifiers other than full names in waiting areas when feasible, and training workforce on common patterns.

What converts incidental into impermissible is the absence of safeguards: an unprotected workstation in a public area, charts left open on a counter, or systematic loudspeaker pages with diagnoses. The Privacy Rule's "reasonable" standard accommodates real-world clinical operations.

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.